...
首页> 外文期刊>Japanese heart journal >Comparison of Long-term Efficacy of Medical Treatment versus Coronary Artery Bypass Grafting (CABG) in Multivessel Coronary Artery Disease
【24h】

Comparison of Long-term Efficacy of Medical Treatment versus Coronary Artery Bypass Grafting (CABG) in Multivessel Coronary Artery Disease

机译:药物治疗与冠状动脉旁路移植术(CABG)在多支冠状动脉疾病中的长期疗效比较

获取原文
           

摘要

The longterm results of medical therapy and coronary artery bypass grafting (CABG) were compared in patients with multivessel disease. All patients were confirmed to have≥75% luminal narrowing of major coronary arteries by coronary arteriogram. When multivessel disease was stratified into double and triple vessel disease, the outcomes varied. In triplevessel disease, the outcome with CABG was good, but the outcome was unfavorable in those employing medical therapy, particularly in patients with decreased left ventricular (LV) function. In patients with doublevessel disease with good LV function, the longterm results with medical therapy were just as favorable as those with CABG. However, doublevessel disease complicated by reduced LV function (ejection fraction≤40%) had a clearly less favorable outcome when treated with medical therapy than with CABG. Thus, it is important for patients with multivessel disease to undergo revascularization if indicated, to improve their prognosis. On the other hand, the incidence of cardiac events arising from vein graft occlusions tended to increase in CABG patients after 5 years or more following surgery.
机译:比较了多支血管疾病患者的药物治疗和冠状动脉搭桥术(CABG)的长期结果。冠状动脉造影证实所有患者的主要冠状动脉腔狭窄均≥75%。当将多支血管疾病分为双血管和三血管疾病时,结果会有所不同。在三支血管疾病中,CABG的预后良好,但在接受药物治疗的患者中不利,特别是在左心室(LV)功能下降的患者中。在左室功能良好的双支血管疾病患者中,药物治疗的长期效果与CABG一样好。然而,与CABG相比,药物治疗导致的双血管疾病并发LV功能降低(射血分数≤40%)明显不利。因此,如果有指征,对多支血管疾病患者进行血管重建很重要,以改善其预后。另一方面,CABG患者术后5年或更长时间后,由静脉移植物阻塞引起的心脏事件发生率趋于增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号